ArticleMolecular biology reports2012

Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK.

Yang Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.